The Effect of Cholesterol Lowing and Anti-atherosclerosis of Hanglian Jiedu Tang and Its Components
|更新时间:2024-01-04
|
The Effect of Cholesterol Lowing and Anti-atherosclerosis of Hanglian Jiedu Tang and Its Components
Chinese Journal of Experimental Traditional Medical FormulaeVol. 14, Issue 2, Pages: 74-76(2008)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2008
稿件说明:
移动端阅览
XU Yang1, QIN Meng1, ZHAO Ying-kai2, et al. The Effect of Cholesterol Lowing and Anti-atherosclerosis of Hanglian Jiedu Tang and Its Components[J]. Chinese journal of experimental traditional medical formulae, 2008, 14(2): 74-76.
DOI:
XU Yang1, QIN Meng1, ZHAO Ying-kai2, et al. The Effect of Cholesterol Lowing and Anti-atherosclerosis of Hanglian Jiedu Tang and Its Components[J]. Chinese journal of experimental traditional medical formulae, 2008, 14(2): 74-76.DOI:
The Effect of Cholesterol Lowing and Anti-atherosclerosis of Hanglian Jiedu Tang and Its Components
Objective:To approach the future study and explore for expanding the clinic application of Huanglian Jiedu Tang
We synthesized the relevant data of Huanglian Jiedu Tang and its components on the effect of cholesterol lowing and anti-atherosclerosis.Methods: we review the reports for recent 10 years.Having referred to the latest achievement
we systemly studied the potential advantage and mechanism of Huanglian Jiedu Tang on lowing cholesterol and anti-atherosclerosis.Results: The data of clinic and research indicated that Huanglian Jiedu Tang can not only reduce the concentration of cholesterol in hepatocyte
but also have the effect for treating the risk factor of atherosclerosis.Conclusion: Huanglian Jiedu Tang and its components have some distinct or potential effects on cholesterol lowing and anti-atherosclerosis.The mechanism will be required to future study using modern technology and strategy in order to expand the extent of clinic application.
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Effect of Co-treatment Method of Stagnation of Phlegm and Blood Stasis (Danlou Tablet) on Vascular Endothelial Function in Patients with Atherosclerosis
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Related Author
SONG Wei
ZHANG Zhongyi
QIU Hairong
ZHAO Mei
ZHOU Zubing
SHEN Tao
ZHANG Yong
LIANG Yuqin
Related Institution
Chengdu University of Traditional Chinese Medicine(TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences
Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine